These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35110855)

  • 1. "The Bitter Truth of Sugar"-Euglycemic Diabetic Ketoacidosis due to Sodium-glucose Cotransporter-2 Inhibitors: A Case Series.
    Shah M; Pathrose E; Bhagwat NM; Chandy D
    Indian J Crit Care Med; 2022 Jan; 26(1):123-126. PubMed ID: 35110855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.
    He Z; Lam K; Zhao W; Yang S; Li Y; Mo J; Gao S; Liang D; Qiu K; Huang M; Wu J
    Acta Diabetol; 2023 Mar; 60(3):401-411. PubMed ID: 36576563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus.
    Chauhan S; Manov A; Dhillon GS; Shah P
    Cureus; 2023 Jan; 15(1):e33892. PubMed ID: 36819400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report.
    Sarno MJF; Hernandez DPF; Matulac MO
    Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fall, Fracture, and Two Episodes of Euglycemic Diabetic Ketoacidosis.
    Wasey W; Hutchings S; Dufner A; Okon D; Saleh S
    Cureus; 2022 Jun; 14(6):e25788. PubMed ID: 35812537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertriglyceridemia-Induced Acute Pancreatitis, Euglycemic Diabetic Ketoacidosis and COVID-19 Infection in a Patient With Type 2 Diabetes Taking a Sodium-Glucose Cotransporter 2 Inhibitor.
    Acevedo-Mendez BA; Ye Y; Hajizadeh N; Myers A
    Cureus; 2021 Nov; 13(11):e19828. PubMed ID: 34853772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors be avoided in Covid-19 and other acute Infections?
    Pilianidis G; Papanastasiou G; Tikoudi P; Themistocleous A; Farmakis G; Dolianitis K
    Eur J Case Rep Intern Med; 2024; 11(3):004282. PubMed ID: 38455692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
    Patel K; Nair A
    Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes Mellitus Receiving Oral Therapy.
    Dull RB; Spangler ML; Knezevich EL; Lau BM
    J Pharm Pract; 2019 Apr; 32(2):240-243. PubMed ID: 29241389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemic, high anion-gap metabolic acidosis in patients receiving SGLT-2 inhibitors for diabetes management.
    Kum-Nji JS; Gosmanov AR; Steinberg H; Dagogo-Jack S
    J Diabetes Complications; 2017 Mar; 31(3):611-614. PubMed ID: 27913012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative implications of sodium-glucose cotransporter-2 inhibitors: a case series of euglycemic diabetic ketoacidosis in three patients after cardiac surgery.
    Lau A; Bruce S; Wang E; Ree R; Rondi K; Chau A
    Can J Anaesth; 2018 Feb; 65(2):188-193. PubMed ID: 29168157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
    Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
    Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports.
    Juneja D; Nasa P; Jain R; Singh O
    World J Diabetes; 2023 Aug; 14(8):1314-1322. PubMed ID: 37664476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice.
    Patoulias D; Manafis A; Mitas C; Avranas K; Lales G; Zografou I; Sambanis C; Karagiannis A
    Cardiovasc Hematol Disord Drug Targets; 2018; 18(2):139-146. PubMed ID: 29412120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
    Zughaib MT; Patel K; Leka M; Affas S
    Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of preoperative sodium-glucose cotransporter 2 inhibitors on the incidence of perioperative metabolic acidosis: A retrospective cohort study.
    Iwasaki Y; Sasabuchi Y; Horikita S; Furukawa T; Shiotsuka J; Lefor AK; Sanui M
    BMC Endocr Disord; 2022 Aug; 22(1):209. PubMed ID: 35987618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic diabetic ketoacidosis: A missed diagnosis.
    Nasa P; Chaudhary S; Shrivastava PK; Singh A
    World J Diabetes; 2021 May; 12(5):514-523. PubMed ID: 33995841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report.
    Alkatheeri A; Alseddeeqi E
    J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Euglycemic Diabetic Ketoacidosis: A Review.
    Modi A; Agrawal A; Morgan F
    Curr Diabetes Rev; 2017; 13(3):315-321. PubMed ID: 27097605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-Glucose Cotransporter-2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a Type 2 Diabetic Patient.
    Haddadin R; Aboujamra D; Iraninezhad H
    Cureus; 2023 Dec; 15(12):e51184. PubMed ID: 38283482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.